| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/14/2005 | EP1572947A2 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS |
| 09/14/2005 | EP1572942A2 Live replicating spumavirus vector |
| 09/14/2005 | EP1572910A2 Signal for packaging of influenza virus vectors |
| 09/14/2005 | EP1572888A2 Methods for generating, selecting, and identifying compounds which bind a target molecule |
| 09/14/2005 | EP1572876A2 Transcriptional regulation of target genes |
| 09/14/2005 | EP1572108A2 Functional mutations in respiratory syncytial virus |
| 09/14/2005 | EP1571909A2 Optimized multi-epitope constructs and uses thereof |
| 09/14/2005 | EP1066395B1 Inducible alphaviral gene expression system |
| 09/14/2005 | EP0705344B1 Adenovirus vectors for gene therapy |
| 09/14/2005 | CN1668736A GM-negative EHV-mutants without heterologous elements |
| 09/14/2005 | CN1668637A Molecular antigen arrays using a virus like particle derived from the AP205 coat protein |
| 09/14/2005 | CN1667124A Recombinant adenovirus and its application in malignant tumor treatment |
| 09/14/2005 | CN1219055C A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 09/14/2005 | CN1219054C Structure for recombinant adenovirus with double killer function and application in tumor treatment |
| 09/13/2005 | US6943246 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof |
| 09/13/2005 | US6943019 Methods and vector constructs useful for production of recombinant AAV |
| 09/13/2005 | US6943015 Large scale production of packaged alphavirus replicons |
| 09/13/2005 | US6943012 Helper dependent adenoviral vector system and methods for using the same |
| 09/13/2005 | US6942982 FEBP1 protein vector host cells and method for making FEBP1 protein |
| 09/13/2005 | US6942965 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
| 09/13/2005 | US6942864 use of live, recombinant leporipox virus comprising exogenous DNA, which is operably linked to at least one expression control element and which is incorporated into non-essential region of virus genome, in manufacture of vector vaccine |
| 09/13/2005 | US6942858 Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
| 09/13/2005 | US6942855 recombinant vaccinia virus having a deletion of the region encoding the C-terminal seven amino acids of the E3L gene product and comprising exogenous DNA; use in genetic vaccines for example |
| 09/09/2005 | WO2005082929A2 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays |
| 09/09/2005 | WO2005082020A2 Flavivirus vaccines |
| 09/09/2005 | WO2005054275A3 Nanofiltration of factor vii solutions to remove virus |
| 09/09/2005 | WO2005047481A3 Novel sequences encoding hapatitis c virus glycoproteins |
| 09/09/2005 | WO2005042714A3 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 09/09/2005 | CA2557136A1 Flavivirus vaccines |
| 09/08/2005 | US20050197299 Peptidomimetic protease inhibitors |
| 09/08/2005 | US20050196865 Using chinese hamster ovaries as bioreactors for propagation of heterologous gene sequences |
| 09/08/2005 | US20050196854 Using domiphen bromide to selectively precipitate viral particles from DNA mixtures; ion echange chromatography |
| 09/08/2005 | US20050196750 Bioassay which utilizes invasive cleavage to identify single nucleotide polymorphism; genotyping and organismal classification |
| 09/08/2005 | US20050196412 Vaccine; components, parts, fragments and derivatives, genetic sequences; development of diagnostic and therapeutic compositions for treatment and prophylaxis of AIDS and related disorders; attenuating pathogenic strains of HIV-1 by mutagenizing particular regions of the HIV-1 genome; low risk |
| 09/07/2005 | EP1569686A2 Transmucosal administration of aggregated antigens |
| 09/07/2005 | EP1569509A1 Cryogenically protected viral delivery systems and related manufacture and use |
| 09/07/2005 | CN1665927A Tumor-lysing virus growing selectively in tumor cells |
| 09/07/2005 | CN1665388A Sterilization, stabilization and preservation of functional biologics |
| 09/07/2005 | CN1218038C Horse infectious anemia donkey embryo skin cell weak-toxic vaccine strain and culture method thereof |
| 09/06/2005 | CA2160034C Gibbon ape leukemia virus-based retroviral vectors |
| 09/01/2005 | WO2005080575A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
| 09/01/2005 | WO2005080556A2 Virus purification methods |
| 09/01/2005 | WO2005080417A2 Recombinant viruses with heterologous envelope proteins |
| 09/01/2005 | WO2005080416A1 Feline calicivirus vaccines |
| 09/01/2005 | WO2005080410A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders |
| 09/01/2005 | US20050191747 Recombinant bovine immunodeficiency virus based gene transfer system |
| 09/01/2005 | US20050191727 Modified viral sequences which enhance genic expression in microorganismal host |
| 09/01/2005 | US20050191622 Classifying human red blood cell (RBC) types; blood screening and transfusion |
| 09/01/2005 | US20050191621 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 09/01/2005 | US20050191317 Modified virus like particles; antiobesity agents |
| 09/01/2005 | CA2558685A1 Nucleic acid construct containing fulllength genome of human hepatitis c virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferredthereinto and method of producing hepatitis c viral particle |
| 09/01/2005 | CA2558682A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders |
| 09/01/2005 | CA2556913A1 Solid-fluid composition and uses thereof |
| 09/01/2005 | CA2555412A1 Virus purification methods |
| 08/31/2005 | EP1568779A1 HSV strains for the oncolytic treatment of cancer |
| 08/31/2005 | EP1567190A2 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 08/31/2005 | EP1131456B1 Vectors for gene mutagenesis and gene discovery by gene trapping |
| 08/31/2005 | EP1073721B1 Efficient purification of adenovirus |
| 08/31/2005 | EP1015620B1 Dual selection cassette and plasmids containing same |
| 08/31/2005 | EP0996731B1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 08/31/2005 | CN1662646A Method for culturing hvc virus in vitro |
| 08/31/2005 | CN1662553A Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions |
| 08/31/2005 | CN1662253A Packaged virus-like particles for use as adjuvants: method of preparation and use |
| 08/31/2005 | CN1216985C Hepatitis A virus strain, method for preparing hepatitis A inactivated vaccine and obtained vaccine |
| 08/30/2005 | US6936707 Modified DNA molecule, recombinant containing the same, and uses thereof |
| 08/30/2005 | US6936595 Tumour-specific vector for gene therapy |
| 08/30/2005 | US6936466 Nucleotide sequences coding polypeptide for use in the treatment of hereditary respiratory system disorders |
| 08/30/2005 | US6936425 Attenuated salmonella SP12 mutants as antigen carriers |
| 08/30/2005 | US6936421 Structurally biased random peptide libraries based on different scaffolds |
| 08/30/2005 | US6936256 For controlling Infectious Pancreatic Necrosis Virus (IPNV) in aquatic species |
| 08/30/2005 | US6936243 Adeno-associated viral vector-mediated delivery of DNA to cells of the liver |
| 08/25/2005 | WO2005056584A3 Novel strain of sars-associated coronavirus and applications thereof |
| 08/25/2005 | US20050188440 Nucleotide sequences coding insect hemolymph polypeptide for use in generating disease resistant plants; microbiocides; biological pest control |
| 08/25/2005 | US20050187180 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
| 08/25/2005 | US20050186621 Using host cells to propagate preferential viral proteins for use in generating vaccines aganist microorganismal infection |
| 08/25/2005 | US20050186575 Corona-virus-like particles comprising functionally deleted genomes |
| 08/25/2005 | US20050186563 Expression vector for use as transformation and gene expression tool in genetic engineering; minimum plasmid-based system for the generation of infectious RNA viruses, preferably influenza viruses, from cloned DNA |
| 08/25/2005 | US20050186560 Mammalian cell expressing viral replication protein for use as tool in identifying modulators for treatment of cell proliferative and autoimmune disorders; immunotherapy |
| 08/25/2005 | US20050186553 Isolating leukocytes from plasma using filtration; identifying cells via activated photoactive compounds |
| 08/25/2005 | US20050186224 Attenuated bovine respiratory syncytial virus |
| 08/25/2005 | US20050186223 Virus production |
| 08/25/2005 | US20050186222 Vaccines against West Nile Virus |
| 08/25/2005 | US20050186181 Selective precipitation of viruses |
| 08/25/2005 | US20050186180 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 08/25/2005 | US20050186178 Adenoviral nucleic acid backbone, a heterologous coding sequence encoding granulocyte-macrophage colony stimulating factor |
| 08/24/2005 | EP1566445A2 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/24/2005 | EP0662132B1 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 08/24/2005 | CN1659281A Antiviral therapy on the basis of RNA interference |
| 08/24/2005 | CN1657632A Combination adeno-associated virus of expression human CYP2J2 antigene and its preparation method |
| 08/24/2005 | CN1657631A Recombination adeno-associated virus of expression human antisense phospho lamban gene and its preparation method |
| 08/24/2005 | CN1657103A Virus envelope vector for gene transfer |
| 08/23/2005 | CA2186044C Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 08/23/2005 | CA2094464C Mutant respiratory syncytial virus (rsv) vaccines containing same and methods of use |
| 08/18/2005 | WO2005017125A3 Method for isolation and replication of infectious human hepatitis-c virus |
| 08/18/2005 | US20050182250 Nucleotide sequences coding fluorescent reporter protlein and scaffolds for use as diagnostic and imaging tool in genetic analysis |
| 08/18/2005 | US20050182010 Use of a nucleotide construct stably integrated in the genome of the target cells of the virus, which is able to produce a single transcript or multiple transcripts capable of forming a double-stranded RNA which inhibits replication of the virus |
| 08/18/2005 | US20050181507 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 08/18/2005 | US20050181495 Large scale productions of virus antigen |
| 08/18/2005 | US20050181494 Novel lambda phage display system and the process |
| 08/18/2005 | US20050181458 Bioassay for measuring the proliferation of T-cells in Human papiloma virus |